Clinical Trial Update: HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hepatic arterial infusion with floxuridine (Liver-Tx) plus second-line chemotherapy versus second-line chemotherapy alone for colorecta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Floxuridine (HAI) (floxuridine)
• Liver-Tx
• Second-line chemotherapy (unspecified)

Snippet

Sponsor: Oslo University Hospital | Conditions: Colorectal Cancer, Liver Metastases | Phase 2 | Status: ACTIVE_NOT_RECRUITING